Results 11 to 20 of about 30,345 (207)

Autosomal dominant polycystic kidney disease

The Lancet, 2019
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and one of the most common causes of end-stage kidney disease. Multiple clinical manifestations, such as enlarged kidneys filled with growing cysts, hypertension, and multiple extrarenal complications, including liver cysts, intracranial aneurysms, and ...
Emilie, Cornec-Le Gall, Ahsan, Alam, Ronald D, Perrone   +2 more
exaly   +6 more sources

Sirolimus and kidney growth in autosomal dominant polycystic kidney disease [PDF]

New England Journal of Medicine, 2010
BACKGROUND: In autosomal dominant polycystic kidney disease (ADPKD), aberrant activation of the mammalian target of rapamycin (mTOR) pathway is associated with progressive kidney enlargement. The drug sirolimus suppresses mTOR signaling. METHODS: In this
Kistler, A D, Krauer, F, Kristanto, P, Poster, D, Raina, S, Rentsch, K M, Scheffel, H, Senn, O, Serra, A L, Spanaus, K S, Weishaupt, D, Wüthrich, R P, Young, J   +12 more
core   +3 more sources

Autosomal dominant polycystic kidney disease. [PDF]

Journal of the American Society of Nephrology, 1993
Autosomal dominant polycystic kidney disease (ADPKD) is an important cause of medical morbidity in the United States that affects one-half million persons and accounts for ESRD in about 10% of the chronic dialysis population. In addition to its effects on the kidney, the disease has important manifestations in the cardiovascular system (aneurysms ...
J C, Lieske, F G, Toback
openaire   +4 more sources

Autosomal dominant polycystic kidney disease

Disease-a-Month, 2015
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disease of the kidneys that can cause an irreversible decline in kidney function leading to end-stage renal disease. It is one of the most common hereditary disorders. It is 10 times more common than sickle cell disease and 20 times more common than Huntington's disease.
Jonathan, Silverman, Chaitanya, Desai, Edgar V, Lerma   +2 more
  +7 more sources

Autosomal dominant polycystic kidney disease [PDF]

Clinical Medicine, 2009
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disease with a prevalence of 1:400 to 1:1,000 live births.[1][1] It is the most common genetic cause of renal failure, accounting for 10% of patients on dialysis.
Chern Li, Chow, Albert C M, Ong
openaire   +2 more sources

Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review

Kidney Medicine, 2020
Polycystic kidney disease (PKD) is a multiorgan disorder resulting in fluid-filled cyst formation in the kidneys and other systems. The replacement of kidney parenchyma with an ever-increasing volume of cysts eventually leads to kidney failure. Recently,
Niloofar Nobakht, Ramy M. Hanna, Maha Al-Baghdadi, Khalid Mohammed Ameen, Farid Arman, Ehsan Nobahkt, Mohammad Kamgar, Anjay Rastogi   +7 more
doaj   +1 more source

Management of Pain in Autosomal Dominant Polycystic Kidney Disease and Anatomy of Renal Innervation [PDF]

, 2015
Purpose Chronic pain is a prominent feature of autosomal dominant polycystic kidney disease that is difficult to treat and manage, often resulting in a decrease in quality of life.
Bacallao, Robert L., Bahler, Clinton D., Shumate, Ashley M., Sundaram, Chandru P., Tellman, Matthew W.   +4 more
core   +1 more source

Autosomal dominant polycystic kidney disease with diffuse proliferative glomerulonephritis - an unusual association: a case report and review of the literature

Journal of Medical Case Reports, 2010
Introduction Autosomal dominant polycystic kidney disease is an inherited disorder that is characterized by the development and growth of cysts in the kidneys and other organs.
Kapoor Vinay, Minz Ranjana, Kaur Ravinder, Mohan Harsh, Singh Rajdeep, D'Cruz Sanjay, Sachdev Atul   +6 more
doaj   +1 more source

Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease [PDF]

, 2016
The neurohypophysial hormone arginine vasopressin (AVP) acts by three distinct receptor subtypes: V1a, V1b, and V2. In the liver, AVP is involved in ureogenesis, glycogenolysis, neoglucogenesis and regeneration. No data exist about the presence of AVP in
Alpini, Gianfranco, Carpino, Guido, Franchitto, Antonio, Gaudio, Eugenio, Glaser, Shannon, Mancinelli, Romina, Olivero, Francesca, Onori, Paolo, Pannarale, Luigi, Sferra, Roberta, Venter, Julie, Vetuschi, Antonella   +11 more
core   +1 more source

Identification, Characterization, and Localization of a Novel Kidney Polycystin-1-Polycystin-2 Complex [PDF]

, 2002
The functions of the two proteins defective in autosomal dominant polycystic kidney disease, polycystin-1 and polycystin-2, have not been fully clarified, but it has been hypothesized that they may heterodimerize to form a "polycystin complex" involved ...
Ackermann, Bergsma, Boletta, Cai, Charron, Chen, Foggensteiner, Gallagher, Gonzalez-Perrett, Green, Grupp, Hanaoka, Huan, Hughes, Ibraghimov Beskrovnaya, Ibraghimov Beskrovnaya, Jat, Jat, Lehtonen, Lohning, Lu, Man, Markowitz, Mochizuki, Moy, Nathke, Obermuller, Olmsted, Ong, Ong, Ong, Ong, Pollack, Pritchard, Putney, Qian, Rothman, Scheffers, Tsiokas, Vassilev, Ward, Watnick, Wu, Xu   +43 more
core   +1 more source